Hanger and Numotion Announce Transformative Merger, Creating North America’s Leading Integrated Mobility and Rehabilitation Platform

Austin, TX & Brentwood, TN – [Insert Current Date] – In a landmark development set to reshape the landscape of orthotic, prosthetic, and complex rehabilitation technology services, Hanger Inc. (Hanger) has announced its intent to acquire Numotion. The strategic combination will forge a new entity, "Hanger Numotion," poised to become the preeminent North American platform for comprehensive mobility and independence solutions. This merger is designed to serve over 1.5 million patients annually across the United States and Canada, integrating complementary capabilities in orthotics and prosthetics (O&P), complex rehabilitation technology (CRT), and broader mobility services. The transaction, structured as a cash acquisition of Numotion by Hanger, will see the combined enterprise controlled by Patient Square Capital, a leading healthcare investment firm.

The announcement signifies a pivotal moment for individuals requiring advanced mobility and rehabilitative care. By uniting Hanger’s extensive network of O&P clinics with Numotion’s specialized expertise in CRT and mobility products, the newly formed entity aims to deliver an unparalleled continuum of care, foster innovation, and expand access for a diverse patient population. Industry observers anticipate that this consolidation will drive efficiencies, enhance clinical outcomes, and set new benchmarks for patient-centric service delivery in a rapidly evolving healthcare environment.

Main Facts: A New Era for Mobility and Rehabilitation

The proposed acquisition of Numotion by Hanger Inc. represents a significant strategic realignment within the specialized healthcare services sector. This isn’t merely a corporate transaction; it’s a foundational step towards creating a vertically integrated powerhouse dedicated to empowering individuals with enhanced mobility and independence.

The Genesis of Hanger Numotion:
The combined entity will operate under the banner of Hanger Numotion, a name that reflects the synergistic union of two industry leaders. Hanger Inc., renowned for its extensive network of orthotic and prosthetic patient care services and solutions, brings a legacy of clinical excellence and a broad geographical footprint. Numotion, a dominant force in complex rehabilitation technology and mobility products and services across the U.S. and Canada, contributes its deep specialization in custom mobility solutions, adaptive equipment, and assistive technology.

Strategic Rationale: A Continuum of Care:
The core strategic driver behind this merger is the creation of a seamless, comprehensive platform. Historically, patients requiring O&P services and those needing CRT might navigate separate provider networks. This combination aims to bridge that gap, offering a more integrated journey for patients who often have overlapping or evolving needs. From a prosthetic limb following amputation to a custom power wheelchair for neurological conditions, Hanger Numotion intends to be a single, trusted resource.

Unprecedented Scale and Reach:
Upon completion, Hanger Numotion will boast an impressive operational scale. Hanger currently operates 925 O&P clinics across the U.S., while Numotion maintains over 200 locations throughout North America. This combined network will facilitate a dramatically expanded reach, serving more than 1.5 million patients annually. Such a vast footprint is expected to improve access to specialized care, particularly in underserved regions, and enable more efficient resource allocation.

Leadership and Governance:
A critical aspect of the merger involves leadership transition. Mike Swinford, the seasoned CEO of Numotion since 2014, is slated to become the CEO of the combined Hanger Numotion. Swinford’s track record of scaling Numotion into a mobility leader through sustained growth and diversification, alongside his prior two decades at GE Healthcare Services, positions him as a strategic choice to guide the integrated enterprise. Pete Stoy, the current CEO of Hanger Inc., who has overseen significant transformation within Hanger since 2020, will transition from his role, expressing confidence in Swinford’s ability to lead the combined organization forward.

Financial Control and Investment:
The transaction is structured as an acquisition of Numotion for cash by Hanger. While specific financial terms have not been disclosed, the combined company will be controlled by Patient Square Capital. This firm’s investment signals a strong belief in the long-term growth potential and strategic value of the integrated platform within the healthcare sector. Numotion, previously a portfolio company of AEA Investors, will transition its ownership stake as part of this deal.

Operational Continuity and Brand Identity:
Crucially, both Hanger and Numotion will continue to operate under their existing, well-established brands and maintain their respective clinical operations following the completion of the transaction. This approach aims to preserve brand equity, minimize disruption for patients and employees, and allow for a thoughtful, phased integration of back-office functions and strategic initiatives. The emphasis will be on leveraging complementary strengths rather than immediately consolidating identities.

Chronology: From Independent Journeys to Integrated Vision

The announcement of the Hanger-Numotion merger is the culmination of years of independent growth, market evolution, and strategic foresight by two leading healthcare service providers. Understanding the timeline and the context preceding this deal offers valuable insight into its significance.

The Independent Trajectories:

• Hanger Inc.’s Legacy: Hanger boasts a history stretching back to the American Civil War, originally founded by James Edward Hanger, the first amputee of the war. Over more than 160 years, Hanger evolved into the nation’s largest provider of O&P patient care services. Its growth has been marked by a focus on clinical excellence, technological advancements in prosthetics and orthotics, and a continuous expansion of its clinic network across the U.S. In recent years, under Pete Stoy’s leadership, Hanger has focused on strengthening its national platform, investing in its people, technology, and capabilities to position itself for sustained growth and operational efficiency. The company has navigated complex healthcare reimbursement landscapes, technological shifts, and the evolving needs of its patient base.

• Numotion’s Rise in CRT: Numotion, while a more recent entity in its current form, rapidly established itself as the largest and leading provider of complex rehabilitation technology (CRT) in the U.S. and Canada. CRT encompasses highly individualized, medically necessary mobility products, such as custom power wheelchairs, manual wheelchairs, seating and positioning systems, and other adaptive equipment designed for individuals with significant disabilities or medical conditions. Under the ownership of AEA Investors and the leadership of Mike Swinford since 2014, Numotion has scaled its business through strategic acquisitions, organic growth, and a relentless focus on patient outcomes and customer service. Its expansion into Canada further solidified its North American presence.

The Market Landscape Paving the Way:
The healthcare sector, particularly specialized services like O&P and CRT, has been undergoing significant transformation. Key trends include:

• Aging Demographics: A growing elderly population contributes to an increased incidence of conditions requiring O&P and CRT services.
• Chronic Disease Prevalence: Rising rates of diabetes, cardiovascular diseases, and neurological disorders lead to a greater demand for assistive devices and rehabilitative care.
• Technological Advancements: Continuous innovation in materials, robotics, AI, and digital health tools is revolutionizing the design and functionality of prosthetics, orthotics, and complex mobility equipment.
• Emphasis on Value-Based Care: Payers and providers are increasingly focused on integrated care models that deliver better outcomes at lower costs, incentivizing collaborations and consolidations that can achieve this.
• Consolidation Pressures: Fragmentation in specialized healthcare markets often leads to consolidation as companies seek scale to negotiate better with payers, invest in technology, and withstand regulatory pressures. Private equity firms, like AEA and Patient Square Capital, have played a significant role in driving this consolidation, seeking to optimize operations and unlock value in niche but growing healthcare segments.

The Path to Merger:
While the exact timeline of discussions is not public, it is plausible that the strategic alignment between Hanger and Numotion became increasingly evident over time. Both companies serve patient populations with mobility challenges, albeit through different primary modalities. The idea of a combined, holistic approach to mobility solutions would have naturally emerged as a powerful value proposition. The involvement of Patient Square Capital, a firm explicitly focused on healthcare investments, suggests a well-considered strategic plan aimed at creating a dominant player.

The Announcement and Anticipated Closure:
The public announcement of the merger marks a formal declaration of intent. The transaction is currently projected to close in the fourth quarter of 2026. This extended timeline is customary for deals of this magnitude, allowing ample time for:

• Regulatory Approvals: Scrutiny from antitrust authorities in both the U.S. and Canada to ensure the merger does not unduly stifle competition.
• Due Diligence: Finalizing financial and operational reviews.
• Integration Planning: Developing detailed strategies for combining operations, systems, and cultures while maintaining service continuity.
• Stakeholder Communication: Engaging with employees, patients, referral sources, and payers to ensure a smooth transition.

The period leading up to Q4 2026 will be crucial for both organizations as they prepare for this significant integration, aiming to minimize disruption and maximize the strategic benefits of their union.

Supporting Data: Market Dynamics and Strategic Synergies

The strategic rationale underpinning the Hanger-Numotion merger is deeply rooted in the current dynamics of the O&P and CRT markets, as well as the compelling synergies expected from their combination. This deal is not just about size; it’s about creating a more effective and comprehensive solution for patients with complex mobility needs.

Market Overview: Orthotics & Prosthetics (O&P)

• Definition: Orthotics involves the design, fabrication, and fitting of braces and other devices (orthoses) to support or correct musculoskeletal deformities or weaknesses. Prosthetics deals with the design, fabrication, and fitting of artificial limbs (prostheses) for individuals who have lost a limb due to trauma, disease, or congenital conditions.
• Patient Demographics: The O&P market serves a diverse population, including amputees (estimated 2 million in the U.S., with 185,000 new amputations annually), individuals with spinal cord injuries, cerebral palsy, stroke, diabetes-related foot complications, and various musculoskeletal disorders.
• Market Size and Growth Drivers: The global O&P market is substantial, valued in the tens of billions of dollars, with steady growth projected. Key drivers include:
  • Aging Population: Increased incidence of conditions requiring O&P services.
  • Rise in Chronic Diseases: Diabetes (leading to amputations), peripheral artery disease, and arthritis.
  • Advancements in Technology: Microprocessor-controlled prosthetics, advanced materials, 3D printing, and integrated sensor technologies are improving functionality and patient outcomes.
  • Focus on Rehabilitation and Quality of Life: Growing emphasis on enabling individuals to maintain independence and participate actively in society.
• Hanger’s Position: Hanger has long been a dominant player, known for its extensive network of clinics, clinical expertise, and investment in technology and education. Its scale provides advantages in purchasing, clinical research, and talent development.
• Reimbursement Landscape: O&P services are typically covered by Medicare, Medicaid, and private insurance, but reimbursement policies can be complex and vary, impacting access and provider profitability.

Market Overview: Complex Rehabilitation Technology (CRT) & Mobility

• Definition: CRT refers to highly specialized, individually configured manual and power wheelchairs, seating and positioning systems, and other adaptive equipment designed to meet the unique medical, physical, and functional needs of individuals with severe disabilities or medical conditions. It is distinct from standard durable medical equipment (DME) due to its customization and clinical necessity.
• Target Patient Population: CRT serves individuals with conditions such as spinal cord injuries, cerebral palsy, multiple sclerosis, muscular dystrophy, amyotrophic lateral sclerosis (ALS), traumatic brain injury, and severe neurological disorders. These patients often have lifelong needs for specialized mobility.
• Market Size and Growth Drivers: The CRT market, while smaller than the broader O&P market, is also experiencing robust growth. Drivers include:
  • Technological Innovation: Development of advanced power wheelchair features, sophisticated seating systems, and alternative drive controls (e.g., sip-and-puff, head arrays).
  • Focus on Functional Independence: Increased recognition of the importance of customized mobility solutions in improving quality of life, health outcomes, and participation in community life.
  • Advocacy and Awareness: Strong patient advocacy groups highlighting the critical need for appropriate CRT.
• Numotion’s Position: Numotion has established itself as the market leader in CRT, known for its clinical expertise, product breadth, and comprehensive service model, including assessment, fitting, delivery, and repair. Its strong relationships with clinicians and manufacturers are key assets.
• Reimbursement Landscape: CRT reimbursement is highly complex, often requiring extensive documentation of medical necessity, specific evaluations by qualified professionals (physiatrists, therapists), and approval from specialized funding sources. Advocacy efforts are ongoing to ensure adequate coverage.

Compelling Synergies and Strategic Rationale:

The merger unlocks a multitude of synergies, positioning Hanger Numotion for enhanced market leadership and patient impact:

1. Complementary Services & Holistic Patient Journey: This is the most significant synergy. Many patients requiring O&P services (e.g., a new amputee learning to walk with a prosthesis) may also benefit from CRT (e.g., a custom wheelchair for longer distances or specific daily activities). Conversely, individuals with neurological conditions needing CRT might also require orthotic bracing. The combined entity can offer a truly holistic solution, managing a patient’s mobility needs across their entire journey, from acute injury or diagnosis through long-term rehabilitation and independent living. This integration can lead to better coordinated care, reduced administrative burden for patients, and optimized outcomes.

2. Expanded Access to Care: With a combined network of over 1,100 locations across North America, Hanger Numotion will significantly expand access to specialized services. This scale allows for broader geographic coverage, potentially reaching underserved rural areas, and reduces wait times for assessments and fittings.

3. Enhanced Clinical Expertise and Training: The merger creates a vast pool of O&P clinicians, CRT specialists, and rehabilitation technologists. This combined expertise can foster cross-training, shared best practices, and collaborative problem-solving for complex patient cases. Investment in advanced training programs for both O&P and CRT professionals can elevate the standard of care across the platform.

4. Leveraging Scale for Efficiency and Innovation:

   • Purchasing Power: A larger organization can negotiate more favorable terms with manufacturers of O&P devices, CRT equipment, and components, leading to potential cost savings that can be reinvested into patient care or innovation.
   • Operational Efficiencies: Integration of back-office functions (e.g., billing, HR, IT, supply chain management) can reduce overhead costs and streamline operations.
   • Research and Development: The combined entity will have greater resources to invest in R&D, exploring new technologies, materials, and digital health solutions that benefit both O&P and CRT patients. This could include developing integrated smart devices, predictive analytics for proactive maintenance, or advanced virtual rehabilitation tools.

5. Data and Analytics: A larger patient base generates a wealth of data on patient outcomes, product performance, and service delivery. This data can be leveraged to improve clinical protocols, personalize care plans, demonstrate value to payers, and drive evidence-based innovation.

6. Advocacy and Policy Influence: A unified, scaled organization will have a stronger voice in advocating for favorable reimbursement policies, increased access to care, and supportive legislative frameworks for individuals with disabilities at both state/provincial and federal levels.

The Role of Private Equity:

• Patient Square Capital: As the controlling investor, Patient Square Capital’s involvement underscores the attractiveness of the integrated mobility and rehabilitation market. Private equity firms typically invest with a long-term growth horizon, seeking to optimize operations, drive strategic expansion, and ultimately enhance enterprise value. Their focus on healthcare suggests a belief in the sector’s resilience and growth potential.
• AEA Investors: Numotion’s successful run as a portfolio company of AEA Investors highlights the effectiveness of private equity in scaling specialized healthcare businesses. AEA’s exit through this acquisition represents a successful realization of their investment, demonstrating the value created during their ownership period.

The supporting data paints a clear picture: the Hanger-Numotion merger is a strategically sound move designed to capitalize on market trends, leverage complementary strengths, and deliver enhanced value to patients, clinicians, and investors alike.

Official Responses: Leadership’s Vision and Confidence

The announcement of the Hanger Numotion merger was accompanied by statements from key executives, underscoring their shared vision for the combined entity and their confidence in its future trajectory. These responses highlight the strategic alignment and the commitment to patients that drive this significant integration.

Mike Swinford: Embracing a Unified Vision for Mobility

Numotion CEO Mike Swinford, who will assume the role of CEO for the combined Hanger Numotion, articulated a profound belief in the fundamental purpose uniting both companies. "Our two companies share a fundamental belief in the role mobility can play in improving people’s lives," Swinford stated. This sentiment goes beyond mere business synergy; it speaks to a shared mission-driven ethos that is crucial for success in patient care.

Swinford emphasized the opportunity to build upon the strengths of each organization: "By bringing together our respective experience, capabilities, and passion to serve our customers and patients, we have an opportunity to build on each company’s strengths and help more people across their mobility journeys." This indicates a strategic approach focused on accretion rather than dissolution, aiming to leverage the distinct competencies of Hanger in O&P and Numotion in CRT. His vision for "helping more people across their mobility journeys" encapsulates the continuum of care that the merger is designed to facilitate, from initial intervention to long-term independence.

Expressing gratitude, Swinford acknowledged the contributions of key partners: "I’d like to personally thank Pete for his outstanding leadership, AEA for its strong partnership and commitment as Numotion’s primary investor, and LLR for its longstanding investment in and support of the company." This recognition of past and present collaborators underscores the collaborative spirit that has brought the deal to fruition. Looking ahead, Swinford voiced enthusiasm for the integration process: "I look forward to working with teams across Hanger, Numotion, and Patient Square as we bring our organizations together and advance our shared commitment to helping people live with greater mobility and independence." This statement highlights the collective effort required for a successful merger and the unified goal that will guide the new leadership.

Pete Stoy: A Legacy of Transformation and Confident Transition

Pete Stoy, the current CEO of Hanger Inc., reflected on his tenure with pride and expressed strong confidence in the future leadership. "I am incredibly proud of what our team has accomplished at Hanger and the transformation the business has undergone since I joined the company in 2020," Stoy commented. His statement speaks to a period of significant strategic growth and operational refinement within Hanger, which has positioned the company for this transformative merger. He detailed the achievements: "Together, we have built a stronger, more integrated national platform, invested meaningfully in our people, technology, and capabilities, and positioned Hanger for sustained growth." This paints a picture of a company that has strategically prepared itself for such a large-scale integration, not just reacting to market forces but actively shaping its future.

Stoy’s endorsement of Mike Swinford was unequivocal. "I have worked with Mike closely throughout this process, and I have tremendous confidence in his ability to lead Hanger Numotion following the close of the transaction," he stated. This close collaboration during the merger process suggests a thoughtful and deliberate leadership transition, ensuring continuity and alignment at the highest levels. He further elaborated on Swinford’s qualifications: "He is an accomplished leader who shares our commitment to patients and our people, and I believe he is well-positioned to build on Hanger’s momentum and realize the tremendous potential of the combined organization ahead." This dual emphasis on patient care and employee welfare, alongside strategic growth, reinforces the values that are expected to guide Hanger Numotion. Stoy’s words convey not just a handover of leadership but a strategic baton pass to a leader deemed capable of maximizing the merger’s potential.

Patient Square Capital: The Investor’s Strategic Imperative (Inferred)

While no direct quote from Patient Square Capital was provided in the original article, their role as the controlling investor implies a strong strategic rationale. As a healthcare-focused private equity firm, Patient Square Capital likely sees Hanger Numotion as a unique opportunity to create a dominant, vertically integrated platform in a growing and underserved market. Their investment thesis would typically revolve around:

• Market Leadership: Consolidating two leaders to create an undisputed market leader.
• Operational Excellence: Leveraging scale to drive efficiencies, optimize supply chains, and enhance clinical delivery models.
• Innovation: Funding research and development to bring cutting-edge O&P and CRT solutions to market.
• Expanded Patient Reach: Capitalizing on the combined network to serve more patients across North America.
• Long-Term Value Creation: Believing in the sustained growth of the mobility and rehabilitation sector, driven by demographic shifts and technological advancements.

Their control position suggests a commitment to actively guide the strategic direction of Hanger Numotion, ensuring its long-term success and impact.

These official responses collectively paint a picture of a well-considered, strategically aligned merger, driven by a shared commitment to patient care and a confident vision for future growth under unified leadership.

Implications: Reshaping the Landscape of Mobility and Rehabilitation

The merger of Hanger and Numotion is poised to have far-reaching implications across various stakeholders, from the patients they serve to the broader healthcare industry and the competitive landscape. This transformative event will likely redefine standards, create new opportunities, and present unique challenges.

For Patients: Enhanced Access and Integrated Care

• Positive Implications:
  • Continuum of Care: Patients requiring both O&P and CRT services will potentially benefit from a more integrated, seamless care journey. Instead of navigating separate providers, they may find a unified approach, leading to better coordination, shared patient records (where permissible), and more holistic treatment plans.
  • Expanded Geographic Access: The combined network’s vast footprint could mean reduced travel times for patients, particularly in rural or underserved areas, making specialized care more accessible.
  • Innovation and Technology: Greater resources for R&D could translate into faster adoption of advanced prosthetics, orthotics, and complex mobility devices, offering patients state-of-the-art solutions.
  • Clinical Excellence: The combined expertise and potential for cross-training among clinicians could elevate the overall quality of care and introduce best practices from both fields.
• Potential Concerns:
  • Market Concentration: While the merger aims for efficiency, concerns about reduced competition could arise. This might impact pricing, choice of providers, or the responsiveness of a larger entity to individual patient needs, though regulatory bodies will scrutinize this.
  • Standardization vs. Personalization: While scale can bring efficiencies, maintaining the highly personalized nature of O&P and CRT services will be crucial. Patients with unique needs require tailored solutions, and a large organization must ensure it doesn’t inadvertently move towards a more generalized approach.

For Employees and Clinicians: Opportunities and Adjustments

• Opportunities:
  • Career Growth: Employees and clinicians may find expanded career pathways within a larger, more diversified organization, including opportunities for specialization, management, or cross-functional roles.
  • Enhanced Training and Development: The combined entity will likely invest heavily in professional development, offering advanced training in cutting-edge technologies and interdisciplinary collaboration.
  • Access to Resources: Clinicians could gain access to a broader range of products, technologies, and support resources, improving their ability to serve patients.
  • Shared Best Practices: The integration will foster an environment for sharing clinical expertise and operational best practices between O&P and CRT specialists.
• Adjustments and Challenges:
  • Organizational Restructuring: Mergers often involve some degree of restructuring, which can lead to uncertainty or changes in roles and responsibilities.
  • Cultural Integration: Blending the cultures of two large organizations can be complex and requires careful management to ensure employee engagement and morale.
  • System Integration: Harmonizing IT systems, patient management platforms, and administrative processes will be a significant undertaking, potentially leading to temporary disruptions.

For the Healthcare Industry and Competitors: A New Benchmark

• Market Leadership and Competition: Hanger Numotion will establish a formidable presence, setting a new benchmark for integrated mobility and rehabilitation services. This will put pressure on smaller, independent O&P and CRT providers to either specialize further, seek their own partnerships, or compete on niche services.
• Consolidation Trend: The merger could accelerate the trend of consolidation in specialized healthcare services, as other players seek to achieve similar scale or integrate complementary offerings to compete effectively.
• Innovation Drive: The combined entity’s increased investment in R&D could spur faster innovation across the industry, challenging competitors to keep pace with technological advancements.
• Payer Relations: A larger, more integrated provider will likely have greater leverage in negotiations with insurance companies and government payers, potentially influencing reimbursement policies and care models.
• Referral Networks: The expanded network could strengthen relationships with referring physicians and hospitals, potentially streamlining patient referrals for both O&P and CRT needs.

For Investors: Long-Term Growth and Market Dominance

• Enhanced Value Proposition: Patient Square Capital’s controlling stake suggests a strong belief in the long-term value creation potential of Hanger Numotion, driven by market leadership, operational synergies, and a diversified service offering.
• Stable Growth Market: The underlying demographics and increasing prevalence of chronic conditions ensure a stable and growing demand for O&P and CRT services, making the investment attractive.
• Operational Efficiencies: The potential for significant cost savings through scale and integration can boost profitability and shareholder returns.
• Regulatory Scrutiny: As with any large merger, investors will be mindful of potential regulatory hurdles (e.g., antitrust reviews) that could delay or alter the transaction.

Regulatory Scrutiny: Antitrust Considerations

Given the significant market share that Hanger and Numotion individually hold in their respective fields, the merger will undoubtedly attract scrutiny from antitrust authorities in both the United States (Federal Trade Commission/Department of Justice) and Canada (Competition Bureau). Regulators will assess whether the combination unduly reduces competition, potentially leading to higher prices, reduced choice, or diminished quality for consumers. While the services are complementary, there might be areas of overlap or potential for anti-competitive practices that need to be addressed. The extended closing timeline until Q4 2026 likely accounts for this rigorous regulatory review process.

Future Outlook: Beyond the Merger

Looking ahead, Hanger Numotion could become a platform for further strategic expansion. This might include:

• Digital Health Integration: Developing advanced telehealth capabilities, remote monitoring solutions, and AI-powered analytics to optimize patient care and engagement.
• Expansion into Ancillary Services: Exploring other related rehabilitation services, home care technology, or assistive living solutions to further broaden the continuum of care.
• Global Reach: While currently focused on North America, the success of this model could pave the way for international expansion in select markets.
• Advocacy Leadership: Becoming a leading voice in policy debates concerning disability rights, access to rehabilitative technology, and equitable healthcare funding.

In conclusion, the Hanger-Numotion merger is a bold, strategic move designed to create a unified powerhouse in mobility and rehabilitation. While presenting significant opportunities for improved patient care and operational efficiencies, its success will ultimately depend on effective integration, sustained innovation, and a steadfast commitment to the core mission of enhancing people’s lives through greater mobility and independence. The healthcare industry will be watching closely as this new titan takes shape, poised to redefine the future of specialized rehabilitative care.